In the last trading session, 16.54 million DarioHealth Corp (NASDAQ:DRIO) shares changed hands as the company’s beta touched 1.41. With the company’s per share price at $0.69 changed hands at -$0.1 or -12.45% during last session, the market valuation stood at $26.42M. DRIO’s last price was a discount, traded about -276.81% off its 52-week high of $2.60. The share price had its 52-week low at $0.63, which suggests the last value was 8.7% up since then. When we look at DarioHealth Corp’s average trading volume, we note the 10-day average is 0.57 million shares, with the 3-month average coming to 185.02K.
Analysts gave the DarioHealth Corp (DRIO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended DRIO as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. DarioHealth Corp’s EPS for the current quarter is expected to be -0.16.
DarioHealth Corp (NASDAQ:DRIO) trade information
Instantly DRIO was in red as seen at the end of in last trading. With action -18.78%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -11.97%, with the 5-day performance at -18.78% in the red. However, in the 30-day time frame, DarioHealth Corp (NASDAQ:DRIO) is -11.02% down. Looking at the short shares, we see there were 1.96 million shares sold at short interest cover period of 10.45 days.
The consensus price target for the stock as assigned by Wall Street analysts is 10.75, meaning bulls need an upside of 93.58% from its current market value. According to analyst projections, DRIO’s forecast low is 7.5 with 14 as the target high. To hit the forecast high, the stock’s price needs a -1928.99% plunge from its current level, while the stock would need to soar -986.96% for it to hit the projected low.
DarioHealth Corp (DRIO) estimates and forecasts
Data shows that the DarioHealth Corp share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -52.28% over the past 6 months, a 57.51% in annual growth rate that is considerably higher than the industry average of 14.90%. Year-over-year growth is forecast to reach 31.91% up from the last financial year.
Consensus estimates given by 3 financial analysts project the company’s revenue in the current quarter to hit an average of 7.41M. 1 analysts are of the opinion that DarioHealth Corp’s revenue for the current quarter will be 8.14M. The company’s revenue for the corresponding quarters a year ago was 3.62M and 5.76M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 104.95%. The estimates for the next quarter sales put growth at 41.44%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 34.16%. The 2025 estimates are for DarioHealth Corp earnings to increase by 41.97%.
DRIO Dividends
DarioHealth Corp is expected to release its next quarterly earnings report in February.
DarioHealth Corp (NASDAQ:DRIO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 22.90% of DarioHealth Corp shares while 30.90% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 40.08%. There are 30.90% institutions holding the DarioHealth Corp stock share, with NANTAHALA CAPITAL MANAGEMENT, LLC the top institutional holder. As of 2024-06-30, the company held 6.9429% of the shares, roughly 2.39 million DRIO shares worth $2.85 million.
APPIAN WAY ASSET MANAGEMENT LP holds the second largest percentage of outstanding shares, with 3.9947% or 1.38 million shares worth $1.64 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund . With 355.61 shares estimated at $0.25 million under it, the former controlled 1.04% of total outstanding shares. On the other hand, Fidelity Extended Market Index Fund held about 0.44% of the shares, roughly 150.44 shares worth around $0.1 million.
